The key to ending the HIV epidemic is a vaccine that will provide long-lasting protection and alleviate the need for prevention methods.
Rigor acadêmico, estilo jornalístico
Todos os artigos de New HIV infections
Exibindo todos artigos
Three new HIV vaccine concepts which rely on high-tech designer proteins are being trialled to see if they can stop the virus.
Understanding where there are high numbers of new HIV infections is important to establishing whether interventions are working or not.
Principais colaboradores
-
Medical Scientist at the National Institute for Communicable Diseases; Research Associate at CAPRISA; Research Professor in the School of Pathology, University of the Witwatersrand
-
Research Professor and DST/NRF SARChI Chair of Virus-Host Dynamics, National Institute for Communicable Diseases, CAPRISA Research Associate, University of the Witwatersrand
-
Research Associate/Post Doctoral Researcher and Deputy Laboratory Director at the Botswana Harvard AIDS Institute, Harvard University
-
Regional Director for Africa, IAVI, and Honorary Professor in the Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine
